The Latest UK Government COVID-19 Precautions
We have made numerous improvements to our business and how we operate to make it a COVID secure operating business. But we thought it was worth reminding everyone of the simple steps we can all take to keep the virus under control in the UK.
There are three simple actions we must all do to keep on protecting each other
Wash hands
keep washing your hands regularly
Cover face
wear a face covering in enclosed spaces
Make space
stay at least 2 metres apart - or 1 metre with a face covering or other precautions
For more information
please click here to go to the UK Government's website.
Vegan friendly product range
A new coronavirus vaccine has been shown to be 89% effective in large-scale UK trials. The Novavax jab is the first to show in trials that it is effective against the new virus variant found in the UK, the BBC's medical editor Fergus Walsh said. The UK has secured 60 million doses of the jab, which will be made in Stockton-on-Tees in north-east England. Meanwhile, a single-dose vaccine developed by Janssen is 66% effective, trial results have shown. Janssen, a company owned by Johnson & Johnson, is also investigating whether giving two doses will give either stronger or longer-lasting protection. The company said its initial findings showed one dose prevented 85% of severe cases. Both the Novavax and Janssen jabs will need to be reviewed by regulators before they can be used. The PM welcomed the "good news", with doses of the Novavax jab expected to be delivered in the second half of this year if approved for use by the Medicines and Healthcare Products Regulatory Agency (MHRA), the government said. The UK has so far approved three coronavirus vaccines for emergency use - one from Oxford University and AstraZeneca, another by Pfizer and BioNTech, and a third from drug firm Moderna. The Novavax jab, which is given in two doses, was shown to be 89.3% effective at preventing Covid-19 in participants in its Phase 3 clinical trial in the UK, and around 86% effective at protecting against the new UK variant. The jab's efficacy against the original Covid-19 strain was calculated to be 95.6%. The Phase 3 trials - the final stage before a vaccine is looked at by a regulator - enrolled more than 15,000 people aged between 18-84, of whom 27% were older than 65, US firm Novavax said. In the South African part of the trial, where most of the cases were the South African variant of the virus, the vaccine was 60% effective among those without HIV. Stan Erck, chief executive of Novavax, said the results from the UK trial were "spectacular" and "as good as we could have hoped", while the efficacy in South Africa was "above people's expectations". He told the BBC the manufacturing plant in Stockton-on-Tees should be up and running by March or April, with the company hoping to get approval for the vaccine from the MHRA around the same time. To find out more information and to read the original source of this post, please click here which will take you to the BBC's website.
A new era for the UK has started now that it has fully left the European Commission.
Information on the new national restrictions, including what they mean for working from home and business closures, why they are being introduced and the financial support available. COVID-19 case numbers are rising rapidly across the whole of the UK and in other countries. We must act now to control the spread of the virus. The single most important action we can all take, in fighting coronavirus, is to stay at home, to protect the NHS and save lives. When we reduce our day-to-day contact with other people, we will reduce the spread of the infection. That is why, from Thursday 5 November until Wednesday 2 December, the Government is taking the following action: Requiring people to stay at home, except for specific purposes. Preventing gathering with people you do not live with, except for specific purposes. Closing certain businesses and venues. These new measures have been carefully judged to achieve the maximum reduction in growth in the number of cases, preventing the NHS from being overwhelmed, whilst ensuring that schools, colleges and universities stay open and that as many people as possible continue to work. Until Thursday 5 November, the relevant Local Covid Alert Level measures will continue to apply in the area where you live. From Thursday the national restrictions replace the local restrictions in your area. No new areas will move in the LCAL Very High restrictions between now and Thursday. The new measures will apply nationally for four weeks up to Wednesday 2 December. At the end of the period, we will look to return to a regional approach, based on the latest data. Complying with the new measures will help limit the spread of coronavirus, reduce the impact on the NHS and save lives. They will be underpinned by law which will make clear about what you must and must not do from 5 November. The relevant authorities, including the police, will have powers to enforce the law – including through fines and dispersing gatherings. For more information and to download the NHS App if you haven't already please click here.